WallStSmart

Artivion Inc (AORT)vsGE HealthCare Technologies Inc. (GEHC)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

GE HealthCare Technologies Inc. generates 4390% more annual revenue ($21.64B vs $481.88M). GEHC leads profitability with a 9.9% profit margin vs -3.6%. GEHC appears more attractively valued with a PEG of 2.25. GEHC earns a higher WallStSmart Score of 66/100 (B-).

AORT

Hold

35

out of 100

Grade: F

Growth: 6.0Profit: 3.0Value: 3.0Quality: 6.5
Piotroski: 4/9Altman Z: 1.46

GEHC

Strong Buy

66

out of 100

Grade: B-

Growth: 6.7Profit: 7.0Value: 5.7Quality: 4.5
Piotroski: 2/9Altman Z: 1.34
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AORTSignificantly Overvalued (-28.3%)

Margin of Safety

-28.3%

Fair Value

$31.25

Current Price

$19.40

$11.85 premium

UndervaluedFair: $31.25Overvalued

Intrinsic value data unavailable for GEHC.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AORT1 strengths · Avg: 8.0/10
Price/BookValuation
2.1x8/10

Reasonable price relative to book value

GEHC2 strengths · Avg: 8.0/10
P/E RatioValuation
17.7x8/10

Attractively priced relative to earnings

EPS GrowthGrowth
39.0%8/10

Earnings expanding 39.0% YoY

Areas to Watch

AORT4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$998.73M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
4.9%3/10

Operating margin of 4.9%

PEG RatioValuation
181.502/10

Expensive relative to growth rate

GEHC3 concerns · Avg: 3.0/10
PEG RatioValuation
2.254/10

Expensive relative to growth rate

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.342/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : AORT

The strongest argument for AORT centers on Price/Book.

Bull Case : GEHC

The strongest argument for GEHC centers on P/E Ratio, EPS Growth.

Bear Case : AORT

The primary concerns for AORT are EPS Growth, Market Cap, Operating Margin.

Bear Case : GEHC

The primary concerns for GEHC are PEG Ratio, Piotroski F-Score, Altman Z-Score.

Key Dynamics to Monitor

AORT profiles as a turnaround stock while GEHC is a value play — different risk/reward profiles.

AORT carries more volatility with a beta of 1.28 — expect wider price swings.

AORT is growing revenue faster at 9.2% — sustainability is the question.

GEHC generates stronger free cash flow (793M), providing more financial flexibility.

Bottom Line

GEHC scores higher overall (66/100 vs 35/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Artivion Inc

HEALTHCARE · MEDICAL DEVICES · USA

Artivion Inc. manufactures, processes and distributes implantable human tissues and medical devices worldwide.

GE HealthCare Technologies Inc.

HEALTHCARE · MEDICAL DEVICES · USA

GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.

Want to dig deeper into these stocks?